Simplicity Wealth LLC Takes $1.05 Million Position in The Clorox Company (NYSE:CLX)

Simplicity Wealth LLC acquired a new position in The Clorox Company (NYSE:CLX) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,118 shares of the company’s stock, valued at approximately $1,048,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Redwood Park Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at $26,000. Millstone Evans Group LLC bought a new stake in Clorox in the fourth quarter worth about $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox in the 4th quarter valued at about $31,000. Asset Planning Inc bought a new position in shares of Clorox during the 4th quarter valued at about $32,000. Finally, GKV Capital Management Co. Inc. acquired a new position in shares of Clorox in the 4th quarter worth approximately $32,000. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.5%

Shares of Clorox stock opened at $126.26 on Thursday. The Clorox Company has a 1 year low of $125.77 and a 1 year high of $171.37. The company has a market cap of $15.56 billion, a P/E ratio of 34.50, a P/E/G ratio of 2.62 and a beta of 0.54. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a 50-day moving average price of $135.41 and a 200 day moving average price of $149.05.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period last year, the company earned $1.71 earnings per share. Clorox’s revenue for the quarter was down 8.0% compared to the same quarter last year. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber acquired 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. Citigroup cut their target price on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a research note on Monday, April 14th. Evercore ISI set a $140.00 price objective on Clorox and gave the company an “underperform” rating in a research report on Tuesday, May 6th. UBS Group reduced their price objective on Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research note on Thursday, April 17th. Morgan Stanley cut their target price on Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. decreased their price target on Clorox from $151.00 to $144.00 and set a “neutral” rating for the company in a research report on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $151.23.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.